Facebook  Twitter  Youtube  ISSUU  RSS  Email

Media Contacts

UK
Dominic Kavakeb
dominic.kavakeb@transparency.org.uk
+ 44 (0)20 3096 7695
Out of hours: Weekends; Weekdays (17.30-21.30): +44 (0)79 6456 0340


Twitter

TransparencyUK With #Brexit looming, here are 3 key steps the UK can take in the fight against Corruption: https://t.co/qmyIUzeKXt
TransparencyUK RT @MaggieMrphy: So we agree corruption is a UK issue, so why are all the deadlines slipping? Recommended read from @rose_zussman https://…
TransparencyUK As we leave the EU, we can’t leave our defences against corruption behind! @rose_zussman writes in @raconteur https://t.co/vrtt9D9ZGo

Tag Cloud

Allegations anti-bribery anti-corruption summit anti money laundering bribery BSkyB Cabinet Office Chart companies conflict Corporate Cooperation corrupt capital Corruption corruption in the uk employment film financial secrecy Governance Government health Home Office illicit enrichment intern journalists Letter Leveson Inquiry London Merkel money laundering offshore tax open governance pharmaceuticals PHP Prime Minister Register of Interests Research Resources Social Accountability statement Trustees UK Unexplained Wealth Orders unmask the corrupt UWO vacancies

Stay Informed

Sign up for updates on TI-UK's work & corruption news from around the globe.

Lobbying the NHS

Written by James Sale on Tuesday, 10 February 2015

In February 2014 the UK media claimed that NHS England had, despite prior knowledge, invited a patients group entirely funded by the pharmaceutical industry and headed by a well-known pharmaceutical industry lobbyist to draft a report which could affect future NHS policy. The group is called the Specialised Healthcare Alliance and its Director, John Murray, also heads a lobbying firm whose clients include some of the world’s biggest drug and medical device firms.


In February 2014 the UK media claimed that NHS England had, despite prior knowledge, invited a patients group entirely funded by the pharmaceutical industry and headed by a well-known pharmaceutical industry lobbyist to draft a report which could affect future NHS policy. The group is called the Specialised Healthcare Alliance and its Director, John Murray, also heads a lobbying firm whose clients include some of the world’s biggest drug and medical device firms.

The report referred to is a documentation of an engagement event designed to gather views about the outline principles for a five year commissioning strategy of a £12 billion budget for complex diseases such as cancer and was co-written with James Palmer who overseas this budget.

The Liberal Democrat politician Tessa Munt said that this “called into question the integrity and objectivity of NHS England’s handling of 143 specialised services for millions of people”. These feelings were echoed by Sarah Wollaston a former GP and member of the House of Commons Health Select Committee: “NHS England is increasingly commissioning vast sums of public money and we need to know who is getting invited to sit on what panels and what potential conflicts of interest they might have”.

NHS England and Specialised Healthcare Alliance rejected that the any in appropriate activities had taken place and iterated that the correct procedures for declaring conflicts of interest are in place at NHS England; a statement supported by the Secretary of State for Health Jeremy Hunt.

This story is concerning as it demonstrates that industry backed interest groups are working very closely alongside government to produce documents that could in some way affect policy. What’s more is that the groups’ funding origins appear to have been known to NHS England, yet they were still commissioned without disclosing the potential conflict of interest publically.  

NHS England might have avoided the appearance of impropriety if it had in place a simple electronic register for meetings, hospitality and conflicts of interest so that it could be seen who is lobbying whom and on which issues.

2057

Read 2057 times Last modified on Wednesday, 11 November 2015 10:07
mm

James Sale

James is TI-UK's Project Officer heading the Pharmaceutical and Healthcare Programme. You can follow the programme on Twitter @TIUK_Health.

Leave a Reply

Contact Us | Sitemap | Privacy

UK Charity Number 1112842

Transparency International UK is a chapter of